Devices and method for warm gas therapy is provided. Device comprises a gas warmer assembly to warm a first gas to a temperature in a first temperature range to obtain warm first gas. The device comprises a first delivery unit that can deliver the warm first gas to a main treatment chamber which encloses a sub-treatment chamber to retain heat therein. A second delivery unit can receive a therapeutic gas from a gas supply. The second delivery unit comprises a first portion and a second portion. The first portion substantially passes through the first delivery unit and therapeutic gas in the first portion is warmed by the warm first gas. The second portion delivers the warm therapeutic gas to a sub-treatment chamber. The sub-treatment chamber encloses a body part of a patient.

Devices and method for warm gas therapy is provided. Device comprises a gas warmer assembly to warm a first gas to a temperature in a first temperature range to obtain warm first gas. The device comprises a first delivery unit that can deliver the warm first gas to a main treatment chamber which encloses a sub-treatment chamber to retain heat therein. A second delivery unit can receive a therapeutic gas from a gas supply. The second delivery unit comprises a first portion and a second portion. The first portion substantially passes through the first delivery unit and therapeutic gas in the first portion is warmed by the warm first gas. The second portion delivers the warm therapeutic gas to a sub-treatment chamber. The sub-treatment chamber encloses a body part of a patient.

A hydrogen-containing gas supply system includes one or more hydrogen-containing gas suppliers, one or more acquirers, and a controller. The one or more hydrogen-containing gas suppliers supply a hydrogen-containing gas to one or more areas in a building. The one or more acquirers acquire information indicating that a person is present in the one or more areas. When it is determined that a person is present in a certain area of the one or more areas in accordance with the information acquired by the acquirers, the controller causes at least one of the one or more hydrogen-containing gas suppliers to supply the hydrogen-containing gas to the certain area.

A hydrogen-containing gas supply system includes one or more hydrogen-containing gas suppliers, one or more acquirers, and a controller. The one or more hydrogen-containing gas suppliers supply a hydrogen-containing gas to one or more areas in a building. The one or more acquirers acquire information indicating that a person is present in the one or more areas. When it is determined that a person is present in a certain area of the one or more areas in accordance with the information acquired by the acquirers, the controller causes at least one of the one or more hydrogen-containing gas suppliers to supply the hydrogen-containing gas to the certain area.

A hydrogen supply apparatus includes: an air path having an inlet and an outlet; a fan that is disposed in the air path and produces a flow of air from the inlet to the outlet; a first pipe having an end that forms a first supply port through which to supply hydrogen gas to the air path; a flow control device that is attached to the first pipe and adjusts a flow rate of the hydrogen gas; and a hydrogen gas sensor, disposed downstream of the fan or the end in a direction of flow of the air that detects a concentration of the hydrogen gas in the air path, where the end is disposed between the fan and the outlet or between the fan and the inlet in the air path.

Embodiments of the present invention are directed to devices, systems and methods adapted for implementing intermittent displacement of blood to mitigate peripheral nerve neuropathy such as that induced by chemotherapeutic agents (i.e., chemotherapy-induced neuropathy (CIN)) that are administered to a patient. Such devices, systems and methods advantageously provide for precise, uniform and controlled blood flow occluding (and optionally blood displacing) compression along irregular surfaces of an appendage of a patient. Such precise, uniform and controlled blood occluding compression is imparted upon the epidermal and dermis skin layers within the aforementioned areas of a patient's extremities to decrease the time that free nerve endings located in the epidermal and encapsulated nerve endings located in the dermis skin layers are exposed to nerve damaging chemotherapy chemicals, thereby substantially decreasing CIN caused by prolonged exposure to such chemicals.

A hot plasma disease treatment system includes a mutually connected control system and at least one power supply system, the control system and the power supply system respectively being connected to and controlling a medium gas modulation system, at least one cooling system, at least one hot plasma generator, at least one plasma processing apparatus, a plasma treatment cabin, a detection feedback system, and a tail gas processing system, the medium gas modulation system being connected to the hot plasma generator, the cooling system being arranged on the hot plasma generator, the hot plasma generator and the plasma processing apparatus being connected, the plasma processing apparatus and the plasma treatment cabin being connected, and the plasma treatment cabin and the tail gas processing system being connected.

A hot plasma disease treatment system includes a mutually connected control system and at least one power supply system, the control system and the power supply system respectively being connected to and controlling a medium gas modulation system, at least one cooling system, at least one hot plasma generator, at least one plasma processing apparatus, a plasma treatment cabin, a detection feedback system, and a tail gas processing system, the medium gas modulation system being connected to the hot plasma generator, the cooling system being arranged on the hot plasma generator, the hot plasma generator and the plasma processing apparatus being connected, the plasma processing apparatus and the plasma treatment cabin being connected, and the plasma treatment cabin and the tail gas processing system being connected.

A system for treatment of a wound area of a patient including a first treatment pad comprising a plurality of Light Emitting Diodes (LEDs) for cleaning and exposing a wound area to ultraviolet light, a second treatment pad comprising removal ports for exposing the wound area to a negative pressure, and a control unit interoperably connected to the first and second treatment pads for providing a negative pressure and the ultraviolet light to the wound area.

A portable, personal therapy chamber for provision of infrared radiation therapy. The therapy chamber includes a pair of telescopically positionable cabins that are lightweight and easily portable by a single user. The therapy chamber is configured for use by a single person lying generally prone on a surface. The cabins are disposed to overlie the user and include a plurality of infrared radiation elements that direct infrared energy toward the user's body. When using the therapy chamber, the user's head extends from an open end of the cabin. A facial treatment fixture is integrated with the cabin to be extendable longitudinally from a terminal end thereof and to overlie the user's face/head. The therapy chamber can be configured to provide mild hyperbaric oxygen therapy in addition to infrared therapy.